ERBB2 and cancer: We showed that loss of PRLR expression in HR+ and HER2-E cells caused dedifferentiation in their molecular phenotype and increased their survival, migratory, and invasive properties, all of which are indicators of the acquisition of a cancer stem-like phenotype.